- Home
- JSPR vs SMLR Comparison
JSPR vs SMLR Comparison
Compare JSPR & SMLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JSPR
- SMLR
- Stock Information
- Founded
- JSPR 2018
- SMLR 2007
- Country
- JSPR United States
- SMLR United States
- Employees
- JSPR N/A
- SMLR N/A
- Industry
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- SMLR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- JSPR Health Care
- SMLR Health Care
- Exchange
- JSPR Nasdaq
- SMLR Nasdaq
- Market Cap
- JSPR 323.0M
- SMLR 289.5M
- IPO Year
- JSPR N/A
- SMLR 2014
- Fundamental
- Price
- JSPR $22.48
- SMLR $61.75
- Analyst Decision
- JSPR Strong Buy
- SMLR
- Analyst Count
- JSPR 11
- SMLR 0
- Target Price
- JSPR $73.38
- SMLR N/A
- AVG Volume (30 Days)
- JSPR 206.1K
- SMLR 1.1M
- Earning Date
- JSPR 11-07-2024
- SMLR 11-04-2024
- Dividend Yield
- JSPR N/A
- SMLR N/A
- EPS Growth
- JSPR N/A
- SMLR N/A
- EPS
- JSPR N/A
- SMLR 2.04
- Revenue
- JSPR N/A
- SMLR $58,938,000.00
- Revenue This Year
- JSPR N/A
- SMLR N/A
- Revenue Next Year
- JSPR N/A
- SMLR N/A
- P/E Ratio
- JSPR N/A
- SMLR $28.73
- Revenue Growth
- JSPR N/A
- SMLR N/A
- 52 Week Low
- JSPR $4.00
- SMLR $20.88
- 52 Week High
- JSPR $31.01
- SMLR $79.45
- Technical
- Relative Strength Index (RSI)
- JSPR 52.21
- SMLR 61.11
- Support Level
- JSPR $20.73
- SMLR $57.33
- Resistance Level
- JSPR $26.05
- SMLR $69.67
- Average True Range (ATR)
- JSPR 1.60
- SMLR 9.09
- MACD
- JSPR -0.10
- SMLR -0.32
- Stochastic Oscillator
- JSPR 48.48
- SMLR 51.22
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
About SMLR Semler Scientific Inc.
Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.